252 related articles for article (PubMed ID: 15819668)
1. Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003.
Busch MP; Tobler LH; Saldanha J; Caglioti S; Shyamala V; Linnen JM; Gallarda J; Phelps B; Smith RI; Drebot M; Kleinman SH
Transfusion; 2005 Apr; 45(4):492-9. PubMed ID: 15819668
[TBL] [Abstract][Full Text] [Related]
2. The 2003 West Nile virus United States epidemic: the America's Blood Centers experience.
Kleinman S; Glynn SA; Busch M; Todd D; Powell L; Pietrelli L; Nemo G; Schreiber G; Bianco C; Katz L;
Transfusion; 2005 Apr; 45(4):469-79. PubMed ID: 15819665
[TBL] [Abstract][Full Text] [Related]
3. Reacting to an emerging safety threat: West Nile virus in North America.
Stramer SL
Dev Biol (Basel); 2007; 127():43-58. PubMed ID: 17486880
[TBL] [Abstract][Full Text] [Related]
4. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.
Busch MP; Glynn SA; Wright DJ; Hirschkorn D; Laycock ME; McAuley J; Tu Y; Giachetti C; Gallarda J; Heitman J; Kleinman SH;
Transfusion; 2005 Dec; 45(12):1853-63. PubMed ID: 16371038
[TBL] [Abstract][Full Text] [Related]
5. Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic.
Tobler LH; Bianco C; Glynn SA; Schreiber GB; Dille BJ; Prince HE; Lanciotti RS; Linnen JM; Gallarda J; Shyamala V; Smith D; Kleinman SH; Busch MP;
Transfusion; 2005 Apr; 45(4):480-6. PubMed ID: 15819666
[TBL] [Abstract][Full Text] [Related]
6. Relative distribution of West Nile virus RNA in blood compartments: implications for blood donor nucleic acid amplification technology screening.
Lai L; Lee TH; Tobler L; Wen L; Shi P; Alexander J; Ewing H; Busch M
Transfusion; 2012 Feb; 52(2):447-54. PubMed ID: 21827506
[TBL] [Abstract][Full Text] [Related]
7. Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making.
Custer B; Tomasulo PA; Murphy EL; Caglioti S; Harpool D; McEvoy P; Busch MP
Transfusion; 2004 Nov; 44(11):1547-54. PubMed ID: 15504158
[TBL] [Abstract][Full Text] [Related]
8. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing.
Busch MP; Caglioti S; Robertson EF; McAuley JD; Tobler LH; Kamel H; Linnen JM; Shyamala V; Tomasulo P; Kleinman SH
N Engl J Med; 2005 Aug; 353(5):460-7. PubMed ID: 16079369
[TBL] [Abstract][Full Text] [Related]
9. West Nile virus blood transfusion-related infection despite nucleic acid testing.
Macedo de Oliveira A; Beecham BD; Montgomery SP; Lanciotti RS; Linnen JM; Giachetti C; Pietrelli LA; Stramer SL; Safranek TJ
Transfusion; 2004 Dec; 44(12):1695-9. PubMed ID: 15584982
[TBL] [Abstract][Full Text] [Related]
10. West Nile virus in Canadian blood donors.
Cameron C; Reeves J; Antonishyn N; Tilley P; Alport T; Eurich B; Towns D; Lane D; Saldanha J
Transfusion; 2005 Apr; 45(4):487-91. PubMed ID: 15819667
[TBL] [Abstract][Full Text] [Related]
11. A modeling framework for evaluation and comparison of trigger strategies for switching from minipool to individual-donation testing for West Nile virus.
Biggerstaff BJ; Petersen LR
Transfusion; 2009 Jun; 49(6):1151-9. PubMed ID: 19309472
[TBL] [Abstract][Full Text] [Related]
12. West Nile virus adheres to human red blood cells in whole blood.
Rios M; Daniel S; Chancey C; Hewlett IK; Stramer SL
Clin Infect Dis; 2007 Jul; 45(2):181-6. PubMed ID: 17578776
[TBL] [Abstract][Full Text] [Related]
13. Detection of West Nile virus in blood donations--United States, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Aug; 52(32):769-72. PubMed ID: 12917583
[TBL] [Abstract][Full Text] [Related]
14. West Nile virus transmission through blood transfusion--South Dakota, 2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Feb; 56(4):76-9. PubMed ID: 17268405
[TBL] [Abstract][Full Text] [Related]
15. Performance characteristics of the Food and Drug Administration-licensed Roche Cobas TaqScreen West Nile virus assay.
Pai A; Kleinman S; Malhotra K; Lee-Haynes L; Pietrelli L; Saldanha J
Transfusion; 2008 Oct; 48(10):2184-9. PubMed ID: 18694466
[TBL] [Abstract][Full Text] [Related]
16. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
Busch MP
Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
[TBL] [Abstract][Full Text] [Related]
17. West Nile virus testing experience in 2007: evaluation of different criteria for triggering individual-donation nucleic acid testing.
Kleinman SH; Williams JD; Robertson G; Caglioti S; Williams RC; Spizman R; Morgan L; Tomasulo P; Busch MP
Transfusion; 2009 Jun; 49(6):1160-70. PubMed ID: 19320866
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of routine individual donation testing for West Nile virus RNA during epidemic season using the investigational Roche cobas TaqScreen West Nile virus test and cobas s 201 system prototype.
Galel SA; Webster J; Roa L
Transfusion; 2008 Jul; 48(7):1486-94. PubMed ID: 18466179
[TBL] [Abstract][Full Text] [Related]
19. Transfusion-associated transmission of West Nile virus--Arizona, 2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Sep; 53(36):842-4. PubMed ID: 15371966
[TBL] [Abstract][Full Text] [Related]
20. First report of human immunodeficiency virus transmission via an RNA-screened blood donation.
Delwart EL; Kalmin ND; Jones TS; Ladd DJ; Foley B; Tobler LH; Tsui RC; Busch MP
Vox Sang; 2004 Apr; 86(3):171-7. PubMed ID: 15078251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
